Trial Hypothesis
Patients meeting the inclusion criteria and treated with titrated therapeutic hypothermia (32-35°C) will have reduced morbidity and mortality rates compared to those receiving standard care alone after traumatic brain injury when assessed by GOSE at 6months.
Please see Trial Summary sheet for further information.
Please follow this link for access to all data collection forms
Please find here the Eurotherm Protocol Version 6